Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL524425 | 1.00 | — | — | |
| Bromide SCHEMBL29096722 | 0.97 | — | — | |
| SCHEMBL233483 | 0.97 | — | — | |
| Bromide SCHEMBL1649333 | 0.92 | — | — | |
| Sulfuric Acid SCHEMBL4408205 | 0.85 | CYP1A2 (0.76) | — | |
| Bromide SCHEMBL17747992 | 0.84 | HRH4 (1.00) | — | |
| Bromide SCHEMBL4434174 | 0.83 | CYP1A2 (0.95) | — | |
| SCHEMBL9197363 | 0.80 | — | — | |
| Bromide SCHEMBL8582620 | 0.79 | HRH4 (0.77) | — | |
| Bromide SCHEMBL31317494 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9737875-B2 | Affinity reagents for protein purification | IMPOSSIBLE FOODS INC. (US) | 2017-08-22 | — | — | US | claimed |
| CN-120265000-A | Preparation method of S- (2-aminoethyl) isothiouronium bromonium hydrobromide field-based passivated inorganic perovskite solar cell | 南开大学 | 2025-07-04 | — | — | CN | disclosed |
| EP-3473710-B1 | SACCHARIFICATION REACTION SOLUTION, SACCHARIFYING ENZYME COMPOSITION, SUGAR PRODUCTION METHOD, AND ETHANOL PRODUCTION METHOD | NISSAN CHEMICAL CORP (JP) | 2023-09-27 | — | — | EP | disclosed |
| CN-109312318-B | Saccharification reaction liquid, saccharifying enzyme composition, method for producing sugar, and method for producing ethanol | 日产化学株式会社 | 2022-06-03 | — | — | CN | disclosed |
| US-11001867-B2 | Saccharification reaction mixture, saccharification enzyme composition, sugar production method, and ethanol production method | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2021-05-11 | — | — | US | disclosed |
| US-20190300921-A1 | SACCHARIFICATION REACTION MIXTURE, SACCHARIFICATION ENZYME COMPOSITION, SUGAR PRODUCTION METHOD, AND ETHANOL PRODUCTION METHOD | NISSAN CHEMICAL CORPORATION (JP) | 2019-10-03 | — | — | US | disclosed |
| EP-3473710-A1 | SACCHARIFICATION REACTION SOLUTION, SACCHARIFYING ENZYME COMPOSITION, SUGAR PRODUCTION METHOD, AND ETHANOL PRODUCTION METHOD | Nissan Chemical Corporation (JP) | 2019-04-24 | — | — | EP | disclosed |
| EP-1551864-B1 | Substrates for detection of TAFI(a) | DSM IP ASSETS BV (NL) | 2011-11-09 | — | — | EP | disclosed |
| EP-1754465-B1 | 2-component initiator system (amine free) with storage stability and especially suitable for acidic systems | HERAEUS KULZER GMBH (DE) | 2011-10-05 | — | — | EP | disclosed |
| US-7718406-B2 | Substrates for TAFI (A) | DSM IP ASSETS B.V. (NL) | 2010-05-18 | — | — | US | disclosed |
| EP-1754465-A1 | 2-component initiator system (amine free) with storage stability and especially suitable for acidic systems | Heraeus Kulzer GmbH (DE) | 2007-02-21 | — | — | EP | disclosed |
| US-20060068457-A1 | Substrates for tafi (a) | PENTAPHARM AG (CH) | 2006-03-30 | — | — | US | disclosed |
| EP-1551864-A1 | SUBSTRATE FOR TAFI (A) | Pentapharm AG (CH) | 2005-07-13 | — | — | EP | disclosed |
| WO-2004031216-A1 | SUBSTRATE FOR TAFI (A) | PENTAPHARM AG (CH) | 2004-04-15 | — | — | WO | disclosed |
| EP-0814792-B1 | MERCAPTO AND SELENO DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHASE | CHILDRENS HOSP MEDICAL CENTER (US) | 2003-05-28 | — | — | EP | disclosed |
| EP-1102067-A1 | METHOD FOR ASSAYING ANTI-GAD ANTIBODY AND KIT | Kyokuto Pharmaceutical Industrial Co. Ltd (JP) | 2001-05-23 | — | — | EP | disclosed |
| WO-1999040940-A1 | LIGANDS OF THE CD47 ANTIGEN, AGENTS BINDING THE LIGANDS OF THE CD47 ANTIGEN AND USES THEREOF | SARFATI MARIE (CA) | 1999-08-19 | — | — | WO | disclosed |
| EP-0276631-B1 | WETTABLE SURFACE MODIFIED CONTACT LENS FABRICATED FROM AN OXIRANE CONTAINING HYDROPHOBIC POLYMER | CIBA-GEIGY AG (CH) | 1991-05-29 | — | — | EP | disclosed |
| US-4734475-A | Wettable surface modified contact lens fabricated from an oxirane containing hydrophobic polymer | CIBA-GEIGY CORPORATION (US) | 1988-03-29 | — | — | US | disclosed |
| EP-0245669-A2 | Pharmaceutical preparation for preventing damage to living cells by free radicals, or for increasing the efficacy of organic sulphur compounds, and process for increasing the life span of isolated organs | Medopharm Arzneimittelwerk Dr. Zillich GmbH & Co. (DE) | 1987-11-19 | — | — | EP | disclosed |